Abstract
Background: the presence of CMBs has been considered to be an early imaging marker of bleeding-prone angiopathy, and thereby as a predictor of the development of symptomatic stroke, especially intracerebral hemorrhage, and dementia in the elderly. Aim Of The Study: The main goal of this study was to investigate the prevalence and risk factors associated with cerebral miocrobleeds (CMB) in acute ischemic stroke by using T2* weighted imaging study. Patients and methods: this Prospective Cohort Study was conducted during a period of 6 months . Totally 150 cases were included in this study at inpatient departments and outpatient clinics of Al-Azhar neurology departments at Al-Azhar University Hospitals. with clinically, radiologically and lab diagnosed as acute ischemic stroke. MRI brain T2* was used to asses presence or absence of cerebral microbleeds. Results: The prevalence of cerebral microbleeds was 21.3%% .no statistically significant differences were found between negative-CMB and positive CMB as regard each of being smoker, hypertensive, diabetic, having atrial fibrillation, ischemic heart disease or hyperlipidemia. The present results revealed that there was a statistically significant increase in antiplatelet medication among patients with positive CMB in comparison with negative CMB. Conclusion:The prevalence of cerebral microbleeds was 21.3%% in the elderly population of patients suffering from ischemic stroke. Antiplatelet medications emerged as the most important associated risk factors for the presence of CMBs.
Article Type
Original Article
Keywords
Cerebral Microbleeds; Acute ischemic stroke; MRI Brain
How to Cite This Article
Ghaly, Ahmed; ELZAYAT, SAYED; ALI, AHMED; and ELSHAMY, MAHMOUD
(2022)
"Evaluation of Cerebral Microbleeds in Patients with Acute Ischemic Stroke,"
Al-Azhar International Medical Journal: Vol. 3:
Iss.
11, Article 10.
DOI: https://doi.org/10.21608/aimj.2022.142376.1964
